{"id":"cd1f5d62-596c-48b2-aa56-98dd2e4ec7b5","slug":"burstdr-spinal-cord-stimulation-for-chemotherapy-induced-peripheral-neuropathy","title":"BurstDR™ spinal cord stimulation for chemotherapy-induced peripheral neuropathy","authors":["Stephen Jaffee","Jyothika Mamagdi","Miriam Vaezi","Trent Kite","Bhavika Gupta","Samuel Valleta","Feno Monaco","Nestor Tomycz"],"abstract":"Background: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common persistent adverse effects of chemotherapy affecting cancer survivors. Other than the use of duloxetine, no other intervention has a proven benefit for these patients. Here, a patient with multiple myeloma who developed CIPN experienced a significant reduction in their symptoms after the implantation of a spinal cord stimulator. Case Description: A 64-year-old male with a history of multiple myeloma presented with chronic pain 4 years after chemotherapy, followed by an autologous stem cell transplant. As the patient’s symptoms were refractory to medical management, he underwent placement of a permanent spinal cord stimulator, resulting in 80% relief of calf pain and a 60% improvement in foot paresthesias/pain. Conclusion: Spinal cord stimulation proved effective in treating CIPN (CIPN following autologous stem cell transplant) in a 64-year-old male treated 4 years ago for multiple myeloma.","thumbnailUrl":"https://sni-digital-videos.s3.amazonaws.com/articles/cd1f5d62-596c-48b2-aa56-98dd2e4ec7b5/featured/hero-cropped-1781558551889.jpg","publishDate":"2025-06-06T00:00:00.000Z","doi":"10.25259/SNI_284_2025","categories":["Pain","Case Report"],"fullTextUrl":"https://surgicalneurologyint.com/api/articles/cd1f5d62-596c-48b2-aa56-98dd2e4ec7b5/pdf"}